Previous Article | Next Article 
Journal of Bacteriology, May 1999, p. 3025-3032, Vol. 181, No. 10
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Phosphate Control of Oxytetracycline Production by
Streptomyces rimosus Is at the Level of Transcription
from Promoters Overlapped by Tandem Repeats Similar to Those of the
DNA-Binding Sites of the OmpR Family
Kenneth J.
McDowall,1
Arinthip
Thamchaipenet,2 and
Iain S.
Hunter3,*
Faculty of Biological Sciences, University of
Leeds, Leeds LS2 9JT,1 and Department of
Pharmaceutical Sciences, University of Strathclyde, Glasgow G1
1QW,3 United Kingdom, and Department of
Genetics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand2
Received 30 November 1998/Accepted 22 February 1999
 |
ABSTRACT |
Physiological studies have shown that Streptomyces
rimosus produces the polyketide antibiotic
oxytetracycline abundantly when its mycelial growth is limited by
phosphate starvation. We show here that transcripts
originating from the promoter for one of the biosynthetic genes,
otcC (encoding anhydrotetracycline oxygenase), and from a
promoter for the divergent otcX genes peak in abundance at
the onset of antibiotic production induced by phosphate starvation, indicating that the synthesis of oxytetracycline is controlled, at
least in part, at the level of transcription. Furthermore, analysis of
the sequences of the promoters for otcC, otcX,
and the polyketide synthase (otcY) genes revealed
tandem repeats having significant similarity to the DNA-binding sites
of ActII-Orf4 and DnrI, which are Streptomyces
antibiotic regulatory proteins (SARPs) related to the OmpR family of
transcription activators. Together, the above results suggest that
oxytetracycline production by S. rimosus
requires a SARP-like transcription factor that is either produced
or activated or both under conditions of low phosphate concentrations. We also provide evidence consistent with the
otrA resistance gene being cotranscribed with
otcC as part of a polycistronic message, suggesting a
simple mechanism of coordinate regulation which ensures that
resistance to the antibiotic increases in proportion to production.
 |
INTRODUCTION |
Oxytetracycline
(5'-hydroxytetracycline; OTC), a polyketide antibiotic
(48) effective against a broad spectrum of microorganisms, is produced by strains of Streptomyces rimosus (for reviews,
see references 5 and 27).
Environmental factors, such as carbon and nutrient sources,
temperature, and method of cultivation can affect the timing and extent
of production of this antibiotic, as has been found for many other
secondary metabolites (30, 35). However, OTC production is
particularly sensitive to phosphate; i.e., OTC can be produced
abundantly only in media containing levels of phosphate lower than that
required for rapid mycelial growth (3, 4). Moreover, by
starving cultures of only phosphate, it is possible to induce abundant
OTC production by S. rimosus, including the Pfizer
production lineage derived from strain 4018 (42). To date,
the molecular basis of phosphate regulation of OTC production by
S. rimosus has not been investigated beyond showing
that the activity of one of the biosynthetic enzymes, anhydrotetracycline oxygenase, is lower in mycelia grown in excess phosphate (2, 8).
The cellular activity of enzymes associated with the production of
other antibiotics has also been found to be regulated by phosphate;
these include p-aminobenzoate (PABA) synthase from the
candicidin producer S. griseus and
deacetoxycephalosporin C synthase from S. clavuligerus
and Cephalosporium acremonium (for a review, see reference
31). The structural gene (pabS) and
promoter for PABA synthase have been cloned and characterized (18,
19, 41). Comparison of the cellular levels of transcripts originating from the pabS promoter has revealed that they
are higher when phosphate is limiting, suggesting that the cellular activity of PABA synthase is controlled, at least in part, at the level
of transcription (1). For deacetoxycephalosporin C synthase
from S. clavuligerus and C. acremonium,
there is evidence that the catalytic activity of this enzyme is
inhibited by growth in medium containing high levels of phosphate
(55), indicating that transcription may not be the only
level at which regulation occurs.
The otc biosynthetic genes are clustered and are flanked by
two resistance genes in a 34-kb segment of the S. rimosus chromosome (9) that is sufficient to confer OTC
production when introduced on a plasmid into the heterologous
hosts S. albus and S. lividans (6). Much of the otc cluster, including a
6.6-kb region (Fig. 1) that contains
the gene encoding anhydrotetracycline oxygenase (otcC), has been sequenced (27). Upstream and
reading in the direction opposite that of otcC are two
genes (otcX-orf1 and orf2) with unknown
functions. Given this genetic organization, we considered it likely
that any elements controlling the transcriptional initiation of
otcC would be located in the intergenic region between
otcC and otcX-orf1. Here we report the mapping of
promoters within this region and provide evidence that they are
activated, when mycelial growth is limited by phosphate starvation, by
a transcriptional factor related to ActII-Orf4 and DnrI of the
actinorhodin and daunorubicin clusters, respectively (16,
46). This switch may also regulate OTC resistance, as the
otcC transcript appears to be polycistronic and to include
the otrA gene, whose product, a homologue of elongation
factor G (14), protects ribosomes from translational arrest
(40). In addition, we show that the three major promoters of
the polyketide synthase complex (otcY) share common
regulatory motifs with otcC.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Genetic organization at the otrA end of the
otc cluster. Shaded boxes indicate the positions of
identified genes. The triangles within each box show the direction of
translation. The stem-loop structure indicates the position of a
rho-independent terminator (10), and the arrows ( )
indicate the positions of the otrAp1 promoter
(14) and the otcCp1 and
otcXp1 promoters identified here. Only the
restriction sites mentioned in the text are shown: H,
HindIII; Hc, HincII; B, BamHI; P,
PstI; Sm, SmaI; Sp, SphI; A,
AvaI; and S, SstI.
|
|
 |
MATERIALS AND METHODS |
Streptomyces strains, growth conditions, and
bacteriophage M13-based constructs.
S. rimosus 4018 (42) and 15883 were derived by Pfizer Ltd. (Sandwich, Kent,
United Kingdom) during a strain improvement program. 15883S was derived
from 15883 by spontaneous deletion of the OTC gene cluster. To analyze
otc transcription during antibiotic fermentation, 15883 was
grown in Trusoya Medium 1 (TSM1), a proprietary medium from Pfizer
which contains soya flour, starch, vegetable oil, and inorganic salts
(7), while 4018 was grown in liquid complete medium (LCM)
(42). Control RNA was isolated from 15883S grown in tryptone
soya broth (TSB) (25). Cultures (50 ml) were grown in 250-ml
Erlenmeyer flasks at 28°C with shaking (250 rpm). All of the
constructs used to generate single-stranded DNA (ssDNA) probes for the
analysis of transcription were derived from M13mp18 (54).
mL6A has, in the SmaI site, a 2.1-kb SmaI
fragment containing the intergenic region between otcC and
otcX; the insert is oriented such that the otcC
gene is nearest the HindIII site in the polylinker. In
mL6C, the SmaI insert is in the opposite orientation. mAT12a and mAT12b differ only in the orientation of a 1.4-kb
SphI insert that encodes the otcY2 intergenic
region, which in mAT12a is oriented such that the orf1 gene
is nearest the HindIII site in the polylinker. mKM803
has a 250-bp PstI/SmaI fragment containing the 5'
end of the otcZ gene in the corresponding sites of the
polylinker. Similarly, the insert in mKM804 is a 387-bp
HincII/BamHI fragment containing the 5' end of
the otrA gene.
Measurement of OTC in cultures.
Culture samples (1 ml) were
extracted in 9 ml of HCl (pH 1.7) for 30 min and filtered through
Whatman no. 1 papers. Samples (1 ml) were then analyzed for OTC by
isocratic, ion-paired, reverse-phase high-performance liquid
chromatography with a C18 µBondabank column (Waters) and
a mobile phase of acetonitrile-water (3:7) that contained 5%
(wt/vol) 1-hexanesulfonic acid and that had a pH adjusted to 1.7 with sulfuric acid.
Dry weight determinations.
Whatman GF/C filters (4.7-cm
diameter) were dried for 15 min in a microwave oven set at 150 W and
allowed to cool to room temperature in a desiccator for 30 min. The
weight of each filter was determined to three decimal places. Mycelia
were harvested by passing 5 ml of culture through a dried filter held
in a sintered-glass vacuum unit (Millipore). The filter was washed with
15 ml of distilled H2O, dried, and weighed as described
above, and the net weight was recorded. At least three independent
measurements were used to produce each dry weight value, which had a
standard error of the mean of less than 5%.
Isolation of total RNA.
At the appropriate stage of growth,
50 ml of culture was decanted into a 250-ml flask containing 20 g
of 0.5-cm3 ice pellets prepared by freezing
double-distilled water at
20°C and was mixed by swirling. This step
rapidly lowered the temperature of the culture to ca. 0°C. Using the
protocol described by Hopwood et al. (25), we harvested the
mycelia by centrifugation; the cells were lysed by a modification of
the method of Kirby et al. (29), and the lysate was
extracted with phenol-chloroform. The aqueous phase of the lysate (3.5 ml) was carefully added to the top of 1.5 ml of 5.7 M CsCl-0.1 M EDTA
(density, 1.71 g ml
1) in a 5-ml Polyallomer
centrifuge tube (Beckman) and centrifuged at 35,000 rpm in an SW40
rotor for 16 h at 20°C. The RNA in the pellet was redissolved in
400 µl of 0.1 M NaCl, extracted with 0.5 volumes of phenol-chloroform
and chloroform, precipitated with 2 volumes of ethanol, reharvested by
centrifugation in a Microfuge (12,000 × g for 10 min
at 4°C), washed twice with 70% (vol/vol) ethanol, dried in open
Microfuge tubes at room temperature, and redissolved in 100 µl of
H2O. The concentration of the RNA was determined by
measuring the absorbance at 260 nm, the integrity of the RNA was
checked by testing in 0.8% (wt/vol) agarose-Tris-borate-EDTA gels,
and 10-µg aliquots were stored as ethanol precipitates at
70°C.
Primer extension mapping of RNA 5' ends.
Oligonucleotide
primers were labelled at the 5' ends as described by Sambrook et al.
(43), and 1-ng aliquots were mixed with 10 µg of RNA
precipitate. The nucleic acid mixture was harvested by
centrifugation, washed with 70% (vol/vol) ethanol, and dried in an
open Microfuge tube at room temperature. The oligonucleotide primer was
annealed to the RNA and extended with avian myeloblastosis virus
reverse transcriptase (Pharmacia) as described previously (17), and the reaction was terminated by the addition of an appropriate amount of sequencing gel loading buffer (43);
after heating to 85°C, samples were run in an 8% (wt/vol)
polyacrylamide sequencing gel. The sizes of the extension products were
determined by comparing their migration with that of sequencing ladders
generated from single-stranded M13-derived templates by use of a
Sequenase kit as described by the vendor (Amersham). Single-stranded
M13 templates were prepared as described by Sambrook et al.
(43).
Synthesis of ssDNA probes and nuclease protection assays.
5'-end-labelled or continuously labelled probes were synthesized and
used as described by Sambrook et al. (43). The procedure involved extension of oligonucleotide primers annealed to
single-stranded templates derived from recombinant bacteriophage M13,
digestion of the newly synthesized double-stranded DNA with a suitable
restriction enzyme, and separation of the radiolabelled probe from the
linearized ssDNA template by electrophoresis through a 6% (wt/vol)
polyacrylamide sequencing gel. The position of the probe was determined
by autoradiography, and the probe was eluted from a slab of gel by
overnight incubation in 0.5 ml of 0.5 M ammonium acetate (pH 8.0)-10
mM magnesium acetate-1 mM EDTA-10% (wt/vol) sodium dodecyl sulfate.
The eluate was extracted twice with phenol-chloroform and twice with
chloroform, and the probe was precipitated by the addition of 2.5 volumes of ethanol. The precipitate was harvested by centrifugation in
a microcentrifuge (12,000 × g for 30 min at 4°C),
washed with 70% (vol/vol) ethanol, dried as described above, and
redissolved in 50 µl of H2O. The probe (0.2 pmol) was
mixed with 10 µg of total RNA precipitate, harvested, washed, dried
as described above, and redissolved in 20 µl of hybridization buffer
(43). The hybridization mixture was denatured at 85°C for
10 min, allowed to anneal at 55 to 65°C overnight, and treated with
S1 nuclease (Sigma) or exonuclease VII (Life Technologies). The S1
nuclease reaction mixture (300 µl) contained 375 U of enzyme, and the
reaction was carried out at 37°C for 30 min. The hybridization
mixture was treated with exonuclease VII by the addition of 280 µl of
50 mM Tris-Cl (pH 7.8)-50 mM KCl-10 mM EDTA containing 10 U of enzyme
and incubation at 37°C for 45 min. The reaction was terminated by
extraction with phenol-chloroform and chloroform and processed as
described for the S1 nuclease digestion products (43).
Densitometry scanning.
The intensity of autoradiographic
images was determined with a PDI scanner and software.
 |
RESULTS |
Mapping of promoters within the intergenic region between
otcC and otcX-orf1.
To identify promoters within
the intergenic region between the 5' end of otcC and the 5'
end of otcX-orf1, we first used a primer extension assay to
analyze total RNA isolated from S. rimosus 15883 grown
under conditions that produce OTC and, as a negative control, from
15883S, which has a deletion of the entire otc cluster. Single extension products were obtained for both otcC and
otcX mRNAs (Fig. 2A and B,
respectively). Confirmation that both the otcC and the
otcX extension products terminated at RNA 5' ends and not at
internal secondary structures, which occur frequently in streptomycete
transcripts due to their high (73%) G+C content (15), was
obtained by use of a high-resolution exonuclease VII protection assay
(Fig. 2C and D, respectively). The protected products for
otcC and otcX mRNAs were 5 and 7 nucleotides (nt) longer, respectively, than the corresponding primer extension products
(Fig. 2A and B) because exonuclease VII is only able to digest
single-stranded probes to within a few nucleotides of protected regions
(11). No primer extension or nuclease protection was
obtained with RNA from 15883S, indicating that our assays were specific
for otc transcripts.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Primer extension and nuclease protection analyses of the
otcC and otcX transcripts. (A) Lanes 1 and 2 contain cDNA products extended from oligonucleotide C68 hybridized to
10 µg of total RNA from S. rimosus 15883S grown in
TSB and from S. rimosus 15883 grown in TSM1 for 46 h (see Fig. 6A), respectively. (B) Like panel A, except that the cDNA
products were extended from oligonucleotide X84. (C) Lanes 1 and 2 contain the products of exonuclease VII digestion of otcC
transcripts in 10 µg of total RNA from S. rimosus
15883S and 15883, respectively. (D) Like panel C, except that
otcX transcripts were analyzed. The probe for
otcC transcripts was generated by extending 5'-labelled
oligonucleotide C64 annealed to template mL6A and then cutting with
AvaI, while the otcX transcript probe was
generated by extending oligonucleotide X84 annealed to template mL6C
and then cutting with SphI. Both probes were hybridized with
S. rimosus RNA at 37°C. See Fig. 3 for the sequences
of the primers and the locations of the restriction sites. The
sequencing ladders (lanes A, C, G, and T) for analysis of the
otcC and otcX transcripts were extended from
oligonucleotides C68 and X84 annealed to templates mL6A and mL6C,
respectively. Circles indicate the 3' ends of the products of either
primer extension (A and B) or nuclease protection (C and D) analyses.
The arrows show the deduced 5' ends of the otcC and
otcX transcripts.
|
|
Analysis of the DNA sequence upstream of the positions mapped for the
5' ends of the
otcC and
otcX mRNAs revealed
hexanucleotide
sequences that are centered around positions

10 and

36 (Fig.
3) and that are similar to the
consensus sequences for the

10
and

35 regions of the major class of
promoters in eubacteria
(
22) and in streptomycetes (
26,
45), suggesting that these
5' ends are the starts of primary
transcripts rather than the
5' ends of RNA decay intermediates.
Accordingly, we designated
these conserved hexanucleotide sequences to
be the

10 and

35
regions of promoters
otcCp1
and
otcXp1. Further sequence analysis
revealed a
perfect tandem repeat between positions

41 and

23
of
otcXp1 (Fig.
3). Similarly, a related, but
imperfect, tandem
repeat was located at precisely the same positions in
otcCp1.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 3.
Annotated sequences of otcCp1 and
otcXp1. The positions of the transcription start
sites (bent arrows) are indicated, together with the putative 10 and
35 regions of the promoters (shaded boxes), the direct repeats which
have sequence similarity to the DNA-binding sites of E. coli
PhoB (straight arrows), the primer sequences (unshaded boxes), and
restriction enzyme sites used in mapping the 5' ends of the
otcC and otcX transcripts (see Fig. 2). Potential
ribosome-binding sites (RBS) are shown by shaded circles.
|
|
Tandem repeats also overlap the otcY promoters.
To
determine whether tandem repeats overlapping
35 regions are a general
feature of the promoters of otc biosynthetic genes, we also
mapped and analyzed the sequences of promoters in the intergenic region
between the polyketide synthase genes otcY2-orf1 and
otcY2-orf2. This is the only other segment where
biosynthetic genes diverge in the otc cluster
(27). Single major primer extension products were obtained
for both of the otcY2 transcripts (Fig. 4); moreover, as was found for
otcCp1 and otcXp1, the
promoters in the otcY2 intergenic region were overlapped by
tandem repeats (Fig. 5). Interestingly,
the 11-nt separation (one turn of supercoiled B-form DNA) between the
centers of these repeats and the location of the first repeat 10 nt
upstream of the
10 regions of the otc promoters is typical
of the DNA-binding sites of members of the OmpR family of transcription
factors (32-34, 44, 51).

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 4.
Primer extension analysis of transcription from
divergent promoters in the intergenic region between
otcY2-orf1 and orf2. (A) Lanes 1 and 2 contain
cDNA products extended from primer L12A3 (5'-TCACCACGGCGAGCCCGATG)
hybridized to 10 µg of total RNA from S. rimosus 4018 grown in TSM1 for 2 days and from 15883S grown in
TSB, respectively. (B) Like panel A, except that the cDNA products were
extended from primer L12B1 (5'-AGCGCGGTGTCCACGGGGACGC). The
sequencing ladders (lanes A, C, G, and T) for analysis of the
otcY2-orf1 and orf2 transcripts were extended
from L12A3 and L12B1 annealed to templates mAT12a and mAT12b,
respectively. As in Fig. 2, circles indicate the 3' ends of primer
extension products, and arrows show the deduced 5' ends of the
transcripts.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Alignment of the nucleotide sequences of otc
promoter regions. The transcription start sites (designated +1) were
determined as described in the legends to Fig. 2 and 4. Underlined
sequences are hexanucleotide segments having similarity to consensus
sequences TAG[Pu][Pu]T and TTGAC[Pu], which correspond to the
10 and 35 regions, respectively, of the major class of
streptomycete promoters (22, 49). The putative 35 regions
of the otc promoters are overlapped by tandem repeats
indicated by arrows. To allow a consensus sequence to be derived for
the repeated sequences, the repeat closest to the transcriptional start
site of each promoter was copied, placed within parentheses, and
aligned under its partner. In the consensus sequence for the repeated
sequences, lowercase, uppercase, bold, and underlined characters
represent nucleotides conserved at the same positions in five, six,
seven, and eight of the repeats, respectively. The putative sequence of
the promoter for the otcY1 genes (28) is also
shown but was not used to derive the consensus sequence for the
repeated sequences. The otcY1 promoter is overlapped by
three related repeats whose centers are separated by 11 nt.
|
|
Transcription from otcCp1 and
otcXp1 is regulated.
We investigated
whether transcription from otc promoters overlapped by
tandem repeats is temporally regulated. Primer extension assays were
used to compare the levels of transcripts extending from
otcCp1 and otcXp1 at
different stages during a strain 15883 fermentation that produced
significant levels of OTC (ca. 6 mg ml
1) when phosphate
became limiting. As shown in Fig. 6,
after 18 h, when OTC was barely detectable in the culture (<50
µg ml
1), transcripts originating from
otcCp1 and otcXp1 were
present at low levels; however by 46 h, when antibiotic production
had started, the amount of each transcript had increased 10- to
20-fold. Despite the fact that the amount of OTC in the medium
continued to increase at later times (69 and 93 h), the abundance
of the otcC transcripts declined steadily. The coincidence
of the peak in the abundance of transcripts originating from
otcCp1 and otcXp1 with
the onset of OTC production suggests that the biosynthesis of this
antibiotic is controlled, at least in part, at the level of
transcription.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Quantification of levels of transcripts originating from
otcCp1 and otcXp1 at
different stages during the production of OTC by S. rimosus 15883 grown in TSM1. (A) Open circles indicate the amount
of OTC in the cultures. The values were obtained from samples taken
from 14 cultures (50 ml) that were inoculated and incubated at 28°C
on a rotary platform at the same time. Closed circles indicate the
concentration of OTC in cultures used to analyze otc
transcripts. Crosses and triangles indicate the levels of transcripts
originating from otcCp1 and
otcXp1, respectively, as measured by
densitometry scanning of the autoradiographs of the primer extension
products shown in panel B. (B) Primer extension assays were done as
described in the legend to Fig. 2 with total RNA isolated from
S. rimosus 15883 grown in TSM1 for 18, 46, 69, and
93 h. TSM1 contains a colloidal suspension of starch and soya
flour, which prevented the isolation of RNA and prevented the
measurement of mycelial growth before 18 h.
|
|
Evidence for an otcC-otcC-otrA polycistronic
message.
Previously, it had been shown that the otrA
resistance gene is transcribed in part by read-through from
otcZ, the methyltransferase biosynthetic gene (38,
39) that lies between otrA and otcC (Fig.
1); therefore, if transcription extends from otcC into
otcZ, then otcCp1 could participate
in the regulation of antibiotic resistance as well as biosynthesis.
This possibility was investigated with an S1 nuclease protection assay
(Fig. 7). Two protected species of 252 and 297 nt were detected with total RNA isolated from strains 4018 and
15883 (Fig. 7, lanes 2 and 3 and lane 4, respectively); however, the
297-nt species was also detected with total RNA isolated from strain
15883S (lane 1), indicating that only the 252-nt fragment was protected
by otc transcripts. The length of the
otc-specific fragment corresponded to protection of the
probe by transcripts covering the entire otcC-otcZ
intergenic region between the PstI and SmaI sites
(Fig. 1, positions 4 and 5), indicating that otcZ and thus
otrA could be transcribed from
otcCp1. Consistent with the results of the
protection assay, we were unable to detect any sequence between
otcC and otcZ that was predicted to form a
rho-independent terminator. The 297-nt species detected in all the
samples in Fig. 7 corresponds to the full-length probe protected from
S1 nuclease digestion by a small amount of contaminating template DNA
in the probe preparation (see Materials and Methods).

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 7.
Analysis of transcription in the intergenic region
between otcC and otcZ. High-resolution S1
nuclease protection assays were performed with 10 µg of total RNA
from S. rimosus 15883S grown in TSB until the late
logarithmic phase, 4018 grown in the same manner as 15883S, 4018 producing OTC (ca. 60 µg ml 1) after 56 h in LCM
(see Fig. 9), and 15883 producing OTC (ca. 700 µg ml 1)
after growth in TSM1 (see Fig. 6) for 46 h (lanes 1, 2, 3, and 4, respectively). A continuously labelled ssDNA probe was generated from
template mKM803 by extension of the 20 universal primer and
EcoRI digestion. The sequencing ladder (lanes A, C, G, and
T) was produced by extension of the 40 universal primer annealed to
template mKM803. The numbers on the left indicate the sizes of the
protected probe fragments, as determined by comparison with the
sequencing ladder.
|
|
Attempts to confirm the presence of the 6-kb
otcC-otcZ-otrA polycistronic message by Northern blot
analysis were unsuccessful.
Although
otc-specific RNA
species were detected, they were heterogeneous
in size, from 1.5 to 3.0 kb (data not shown). A possible explanation
for this result is that
decay of the
otcC-otcZ-otrA polycistronic
message commences
before transcription has terminated. In any
case, further evidence
supporting the notion that
otrA is transcribed
from
otcCp1 was obtained by use of a high-resolution
S1 nuclease
protection assay to determine the relative levels of
transcripts
for the segment between
otcZ and
otrA
(Fig.
8) in the RNA samples
used to
analyze transcription from
otcCp1 at different
stages
during OTC production (Fig.
6). The probe used was complementary
to the sense strand between the
HincII and
BamHI
sites (Fig.
1,
positions 2 and 3), and total RNA isolated from strain
15883S
served as a negative control (Fig.
8, lane 1). The 449-nt
species
in the 15883S RNA sample (Fig.
8, lane 1) corresponds to the
full-length
probe, while the 387-nt protected fragment in the RNA
samples
isolated from 15883 at the stages analyzed during the
production
of OTC (lanes 3 to 6) corresponds to transcriptional
read-through
from the
otcZ gene. Consistent with
otrA being transcribed from
otcCp1,
the abundance of transcripts encoding the segment between
the 3' end of
otcZ and the 5' end of
otrA peaked early in OTC
production, at 48 h (compare with Fig.
6). Interestingly, in
strain
15883, no transcription was detected from
otrAp1 (
14), which
lies in the
intergenic region between
otcZ and
otrA; however,
this strain produced detectable levels of transcripts during growth
on
TSB (protection of 166 to 167 nt in Fig.
8, lane 2), a medium
that does
not support antibiotic production.

View larger version (97K):
[in this window]
[in a new window]
|
FIG. 8.
High-resolution S1 nuclease protection analysis of
otrA transcription at the onset of OTC production by
S. rimosus 15883 grown in TSM1. Lanes 1 and 2 contain
probe fragments protected by 10 µg of total RNA from S. rimosus 15883 and 4018 grown in TSB, respectively, while lanes 3, 4, 5, and 6 correspond to 15883 grown in TSM1 for 18, 46, 69, and
93 h, respectively (see Fig. 6). A continuously labelled ssDNA
probe was generated by extension of the 20 universal primer annealed
to template mKM804 and digestion with EcoRI. The sequencing
ladder (lanes A, C, G, and T) was produced by extension of the 40
universal primer annealed to template mKM804 (36). The
numbers on the right indicate the sizes of the protected probe
fragments. Species shorter that 387 nt in lanes 3, 4, 5, and 6 may
represent RNA processing or degradation or an artifact of the S1
nuclease mapping procedure.
|
|
The otc genes are transcribed as mycelial growth
slows.
The fermentation conditions for strain 15883 (Fig. 6) made
it impossible to correlate the transcription of the otc
genes with the phase of mycelial growth or to show that otrA
is transcribed from otrAp1 before antibiotic
production, because TSM1, the production medium developed for 15883, contains insoluble components that interfered with both the measurement
of mycelial growth and the isolation of RNA at early times. We
therefore analyzed transcription during the early stages of OTC
production by strain 4018 grown in LCM, a completely soluble medium. As
shown in Fig. 9, the combined results
from the 4018 fermentation indicate that the onset of OTC production
coincides not only with increased transcription of otrA by
read-through from otcZ but also with the slowing of mycelial
growth and decreased transcription of otrA from its own promoter (otrAp1). The transition between rapid
growth and the stationary phase is also the point at which increased
transcription of the actinorhodin biosynthetic genes in S. coelicolor occurs (20).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 9.
Analysis of otrA transcription and mycelial
growth at the onset of OTC production by S. rimosus
4018 grown in LCM. (A) Open circles indicate the amount of OTC in
samples taken from six cultures (50 ml) that were inoculated at the
same time and incubated at 28°C on the same rotary platform. Closed
circles indicate the concentration of OTC in cultures used to analyze
otc transcripts. Squares indicate the mean dry weight of the
mycelium at different stages in the fermentation. The determination of
dry weight had a variance of less than 5% error for the mean. (B) S1
nuclease protection analysis of otrA transcription. Assay
conditions were as described in the legend to Fig. 8. Lane 1, RNA from
4018 grown in TSB; lanes 2, 3, and 4, RNA from 4018 grown in LCM for
24, 32, and 56 h, respectively.
|
|
 |
DISCUSSION |
Our findings that (i) promoters of otc biosynthetic
genes are overlapped by tandem repeats (Fig. 5), whose spacing
resembles that of the activation sites of the OmpR family of
transcriptional factors, and (ii) transcripts originating from these
promoters reach a peak at the onset of antibiotic production that is
triggered by limiting phosphate (Fig. 6) together suggest that the
expression of some, and possibly all, of the otc
biosynthetic genes is regulated, at least in part, at the level of
transcription by an activation mechanism. Furthermore, this notion
provides a possible explanation for the observation that three
nonoverlapping segments of the otc cluster prevent the
production of OTC by S. rimosus when cloned with
high-copy-number but not low-copy-number plasmids (the switch-off phenomenon [9]). We now know that two of these
segments correlate with the intergenic region between otcC
and otcX-orf1 and the intergenic region between
otcY2-orf1 and otcY2-orf2, which have been shown
here to contain divergent promoters overlapped by tandem repeats (Fig.
5). The third corresponds to the likely location of the promoter for
the transcription of the otcY1 genes, which encode the
minimal polyketide synthase (27). Although the
transcription start site of the otcY1 promoter has not yet
been determined, tandem repeats resembling those overlapping the
otcC-otcX and otcY promoters have been identified
(Fig. 5). Given the above correlation, we suggest that the basis of the
switch-off phenomenon (9) is the sequestration of a
transcriptional activator by an excessive number of plasmid-borne
copies of the otc tandem repeats.
Transcriptional activators are also known to regulate the expression of
antibiotic gene clusters of other streptomycetes, e.g., ActII-Orf4 and
DnrI of the actinorhodin and daunorubicin clusters, respectively
(16, 46). Recently, it has been noted (53) that
these streptomycete antibiotic regulatory proteins (SARPs) are similar
to the DNA-binding domains of the OmpR family (37).
Furthermore, an analysis of the promoter regions of the act
and dnr biosynthetic genes (53) has revealed
tandem repeats which, like the otc repeats identified in
this study, are characteristic of the DNA-binding sites of all members
of the OmpR family (34). Combined with the knowledge that
the dnr tandem repeats were located within footprints of
bound DnrI, Wietzorrek and Bibb (53) suggested that the
tandem repeats identified in the act and dnr
promoter regions are the binding sites of ActII-Orf4 and DnrI,
respectively. We find that in addition to having similar spacing, the
most highly conserved nucleotide positions (underlined) of the
otc tandem repeats (consensus sequence,
5'-GCTCGAA [Fig. 5]) are also the most highly
conserved positions in the proposed DNA-binding sites of ActII-Orf4 and
DnrI [repeat consensus sequence, 5'-TCGAGC(G/C) (53)]. In the case of the dnr repeats, the most
conserved nucleotide positions have been shown to be protected by DnrI
from digestion by DNase I (47). On the basis of the above
similarity, we suggest that the activator of the otc genes
may be a member of the OmpR family, most likely a member of the SARP
group. Experiments are currently under way to identify the factor that
activates transcription from the otc promoters as, unlike
the situation for actinorhodin and daunorubicin, no
sarp-like gene has been identified within the otc
cluster (28).
The experimental system used to investigate OTC production (shown best
in Fig. 9) used limitation by phosphate to arrest the growth of the
culture, at which time antibiotic biosynthesis was induced. Thus,
transcription from the otc promoters occurred in response to
the environmental stress of phosphate limitation. ActII-Orf4 and DnrI,
together with their cognate DNA-binding sites, may also be involved in
mediating phosphate control of the production of actinorhodin
(23) and daunorubicin (12, 47). Consistent with
this notion, detailed physiological studies have shown that phosphate
starvation can induce actinorhodin production at least in part at the
level of transcription of actIII (23, 24), whose
promoter (21) is now known to be overlapped by a proposed DNA-binding site of ActII-Orf4 (53).
At present, the best-characterized phosphate-controlled system is the
pho regulon of Escherichia coli, which encodes a
set of genes required for the uptake of phosphate (for reviews, see references 44 and 51). Under
conditions of low phosphate, PhoB, a transcriptional activator that
(like SARPs) is a member of the OmpR family, is phosphorylated by PhoR
(a sensory kinase) and then binds to promoters to activate the
transcription of genes required for the active uptake of phosphate.
Whether covalent modification of SARPs plays a role in the regulation
of antibiotic production remains to be determined. Interestingly,
however, in E. coli cells that lack functional PhoR, the
pho regulon is no longer under the control of phosphate but
is tightly regulated by carbon and energy sources via controls that
were not obvious under conditions of phosphate starvation in the
presence of functional PhoR (49, 50). Current evidence
suggests that PhoB is activated not only by PhoR but also by other
sensory kinases, thus allowing the process of phosphate assimilation to
be integrated with central pathways for carbon and energy metabolism
(for a review, see reference 51). The notion that
the control of antibiotic production in Streptomyces is
subject to cross regulation, similar to that described above for the
E. coli pho regulon, could explain how factors other than
phosphate, for example, carbon and nitrogen sources, can affect the
timing and extent of antibiotic production (see references 30 and 36).
Regardless of the actual details of the molecular mechanism controlling
antibiotic production, it is important for the survival of the producer
that it is resistant at the onset of biosynthesis. The combined results
of our transcriptional analyses (Fig. 7 to 9) suggest that antibiotic
resistance and production may be coordinated in S. rimosus at least in part via cotranscription of the
otrA resistance gene with the otcC and
otcZ biosynthetic genes from the
otcCp1 promoter.
OTC resistance is also regulated independently of OTC production:
preexposure of S. rimosus to sublethal concentrations
of OTC during vegetative growth induces higher levels of resistance (40). This response is independent of
otcCp1 but probably involves otrAp1, as a DNA segment extending from the 3'
end of otrA to the middle of otcZ is sufficient
to confer inducible resistance (13). At the onset of
antibiotic production, when otrA is transcribed along with
otcZ and otcC, transcription from
otrAp1 appears to be superfluous, as there is a
significant (>80%) decrease in the level of transcripts originating
from this promoter (Fig. 9). The molecular basis of this observation
remains to be determined, but it is conceivable that
otcCp1 and otrAp1 are
transcribed by different RNA polymerase holoenzymes (10, 52)
which are active under different physiological conditions.
 |
ACKNOWLEDGMENTS |
This work was supported by awards of studentships from the
British MRC (to K.J.M.) and the Thai Ministry of Science, Technology and Environment (to A.T.).
We are grateful to Maggie Smith, Craig Binnie, and Mike Butler for
useful discussions and to Mel Warren for assistance with oxytetracycline measurements.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pharmaceutical Sciences, University of Strathclyde, Glasgow G1 1QW,
United Kingdom. Phone: 44 (0) 141 548 4111. Fax: 44 (0) 141 548 4124. E-mail: i.s.hunter{at}strath.ac.uk.
 |
REFERENCES |
| 1.
|
Asturias, J. A.,
P. Liras, and J. F. Martin.
1990.
Phosphate control of pabS gene transcription during candicidin biosynthesis.
Gene
93:79-84[Medline].
|
| 2.
|
Behal, V.,
Z. Hostalek, and Z. Vanek.
1979.
Anhydrotetracycline oxygenase activity and biosynthesis of tetracyclines in Streptomyces aureofaciens.
Biotechnol. Lett.
1:275-318.
|
| 3.
|
Behal, V.
1986.
Enzymes of secondary metabolism: regulation of their expression and activity, p. 264-281.
In
H. Kleinkauf, H. von Dohren, H. Dornauer, and G. Nesemann (ed.), Regulation of secondary metabolite formation. VCH, Weinheim, Germany.
|
| 4.
|
Behal, V.
1987.
The tetracycline fermentation and its regulation.
Crit. Rev. Biotechnol.
5:275-318.
|
| 5.
|
Behal, V., and I. S. Hunter.
1995.
Tetracyclines, p. 359-385.
In
L. C. Vining, and C. Studdard (ed.), Genetics and biochemistry of antibiotic production. Butterworth-Heinemann, Boston, Mass.
|
| 6.
|
Binnie, C.,
M. Warren, and M. J. Butler.
1989.
Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis.
J. Bacteriol.
171:887-895[Abstract/Free Full Text].
|
| 7.
| Butler, M. J. Personal communication.
|
| 8.
| Butler, M. J. Unpublished results.
|
| 9.
|
Butler, M. J.,
E. J. Friend,
I. S. Hunter,
F. Kaczmarek,
D. A. Sugden, and M. Warren.
1989.
Molecular cloning of resistance genes and architecture of a linked gene cluster involved in biosynthesis of oxytetracycline by Streptomyces rimosus.
Mol. Gen. Genet.
215:231-238[Medline].
|
| 10.
|
Buttner, M. J.,
A. M. Smith, and M. J. Bibb.
1988.
At least three different RNA polymerase holoenzymes direct transcription of the agarase gene (dagA) of Streptomyces coelicolor A3(2).
Cell
52:599-607[Medline].
|
| 11.
|
Calzone, F. J.,
F. J. Britten, and E. H. Davidson.
1987.
Mapping of transcripts by nuclease protection assays and cDNA primer extension, p. 611-632.
In
S. L. Berger, and A. R. Kimmel (ed.), Guide to molecular cloning techniques. Academic Press Ltd., London, England.
|
| 12.
|
Dekeva, M. L.,
J. A. Titus, and W. R. Strohl.
1985.
Nutrient effects on anthracycline production by Streptomyces peucetius in a defined medium.
Can. J. Microbiol.
31:287-294[Medline].
|
| 13.
| Doyle, D., and I. S. Hunter. Unpublished
results.
|
| 14.
|
Doyle, D.,
K. J. McDowall,
M. J. Butler, and I. S. Hunter.
1991.
Characterization of an oxytetracycline-resistance gene, otrA, of Streptomyces rimosus.
Mol. Microbiol.
5:2923-2933[Medline].
|
| 15.
|
Enquist, S. D., and S. G. Bradley.
1971.
Characterisation of deoxyribonucleic acid from Streptomyces venezuelae species.
Dev. Ind. Microbiol.
12:2431-2441.
|
| 16.
|
Fernandez-Moreno, M. A.,
J. L. Caballero,
D. A. Hopwood, and F. Malpartida.
1991.
The act cluster contains regulatory and antibiotic export genes, direct targets for translational control by the bldA tRNA gene of Streptomyces.
Cell
66:769-780[Medline].
|
| 17.
|
Fisher, S. H., and L. V. Wray.
1989.
Regulation of glutamine synthase in Streptomyces coelicolor.
J. Bacteriol.
171:2378-2383[Abstract/Free Full Text].
|
| 18.
|
Gil, J. A., and D. A. Hopwood.
1983.
Cloning and expression of a -aminobenzoic acid synthase gene from the candicidin producer Streptomyces griseus.
Gene
25:119-132[Medline].
|
| 19.
|
Gil, J. A.,
G. Naharro,
J. R. Villanueva, and J. F. Martin.
1985.
Characterisation and regulation of -aminobenzoic acid synthase from Streptomyces griseus.
J. Gen. Microbiol.
131:1279-1287[Abstract/Free Full Text].
|
| 20.
|
Gramajo, H. C.,
E. Takano, and M. J. Bibb.
1993.
Stationary-phase production of the antibiotic actinorhodin in Streptomyces coelicolor A3(2) is transcriptionally regulated.
Mol. Microbiol.
7:837-845[Medline].
|
| 21.
|
Hallam, S. E.,
F. Malpartida, and D. A. Hopwood.
1988.
Nucleotide sequence, transcription and deduced function of a gene involved in polyketide antibiotic synthesis in Streptomyces coelicolor.
Gene
74:305-320[Medline].
|
| 22.
|
Hawley, D. K., and W. R. McClure.
1983.
Compilation and analysis of Escherichia coli promoter DNA sequences.
Nucleic Acids Res.
11:2237-2255[Abstract/Free Full Text].
|
| 23.
|
Hobbs, G.,
C. M. Frazer,
D. C. J. Gardner,
F. Flett, and S. G. Oliver.
1990.
Pigmented antibiotic production by Streptomyces coelicolor A3(2): kinetics and the influence of nutrients.
J. Gen. Microbiol.
136:2291-2296.
|
| 24.
|
Hobbs, G.,
A. I. C. Obanye,
J. Petty,
J. C. Mason,
E. Barratt,
D. C. J. Gardner,
F. Flett,
C. P. Smith,
P. Broda, and S. G. Oliver.
1992.
An integrated approach to studying regulation of production of the antibiotic methylenomycin by Streptomyces coelicolor A3(2).
J. Bacteriol.
174:1487-1494[Abstract/Free Full Text].
|
| 25.
|
Hopwood, D. A.,
M. J. Bibb,
K. F. Chater,
T. Kieser,
C. J. Bruton,
H. M. Kieser,
D. J. Lydiate,
C. P. Smith,
J. M. Ward, and H. Schrempf.
1985.
Genetic manipulation of Streptomyces: a laboratory manual.
The John Innes Foundation, Norwich, United Kingdom.
|
| 26.
|
Hopwood, D. A.,
M. J. Bibb,
K. F. Chater,
G. R. Janssen,
F. Malpartida, and C. P. Smith.
1986.
Regulation of gene expression in antibiotic-producing Streptomyces, p. 251-276.
In
I. R. Booth, and C. F. Higgins (ed.), Regulation of gene expression in antibiotic-producing Streptomyces. Cambridge University Press, Cambridge, United Kingdom.
|
| 27.
|
Hunter, I. S., and R. A. Hill.
1997.
Tetracyclines: chemistry and molecular genetics of their formation, p. 659-682.
In
W. R. Strohl (ed.), Biotechnology of industrial antibiotics. Marcel Decker, Inc., New York, N.Y.
|
| 28.
|
Kim, E. S.,
M. J. Bibb,
M. J. Butler,
D. A. Hopwood, and D. H. Sherman.
1994.
Sequences of the oxytetracycline polyketide synthase-encoding otc genes from Streptomyces rimosus.
Gene
141:141-142[Medline].
|
| 29.
|
Kirby, K. S.,
E. Fox-Carter, and M. Guest.
1967.
Isolation of deoxyribonucleic acid and ribosomal ribonucleic acid from bacteria.
Biochem. J.
104:258-262[Medline].
|
| 30.
|
Kleinkauf, H.,
H. von Dohren,
H. Dornauer, and G. Nesemann (ed.).
1986.
Regulation of secondary metabolite formation.
VCH, Weinheim, Germany.
|
| 31.
|
Liras, P.,
J. A. Asturias, and J. F. Martin.
1990.
Phosphate control sequences involved in transcriptional regulation of antibiotic biosynthesis.
Trends Biotechnol.
8:184-189[Medline].
|
| 32.
|
Makino, K.,
H. Shinagawa,
M. Amemura, and A. Nakata.
1986.
Nucleotide sequence of the phoB gene, the positive regulatory gene for the phosphate regulon of Escherichia coli K-12.
J. Mol. Biol.
190:37-44[Medline].
|
| 33.
|
Makino, K.,
H. Shinagawa,
M. Amemura,
S. Kimura,
A. Nakata, and A. Ishihama.
1988.
Regulation of the phosphate regulon of Escherichia coli: activation of pstS transcription by PhoB protein in vitro.
J. Mol. Biol.
203:85-95[Medline].
|
| 34.
|
Makino, K.,
M. Amemura,
T. Kawamoto,
S. Kimura,
H. Shinagawa,
A. Nakata, and M. Suzuki.
1996.
DNA binding of PhoB and its interaction with RNA polymerase.
J. Mol. Biol.
259:15-26[Medline].
|
| 35.
|
Martin, J. F., and A. Demain.
1980.
Control of antibiotic biosynthesis.
Microbiol. Rev.
44:230-251[Free Full Text].
|
| 36.
|
Martin, J. F.,
A. Daza,
J. A. Asturias,
J. A. Gil, and P. Liras.
1988.
Transcriptional control of antibiotic biosynthesis at phosphate-regulated promoters and cloning of a gene involved in the expression of multiple pathways in Streptomyces, p. 424-430.
In
Y. Okami (ed.), Biology of Actinomycetes '88. Japanese Scientific Societies Press, Tokyo.
|
| 37.
|
Martinez-Hackert, E., and A. M. Stock.
1997.
Structural relationships in the OmpR family of winged-helix transcription factors.
J. Mol. Biol.
269:301-312[Medline].
|
| 38.
|
McDowall, K. J.,
D. Doyle,
M. J. Butler,
C. Binnie,
M. Warren, and I. S. Hunter.
1991.
Molecular genetics of oxytetracycline production by Streptomyces rimosus, p. 105-116.
In
D. Noack, H. Krugel, and S. Baumberg (ed.), Genetics and product formation in Streptomyces. Plenum Press, New York, N.Y.
|
| 39.
|
McDowall, K. J.
1991.
Molecular genetics of oxytetracycline production in Streptomyces rimosus. Ph.D. thesis.
University of Glasgow, Glasgow, Scotland.
|
| 40.
|
Ohnuki, T.,
T. Katoh,
T. Imanaka, and S. Aiba.
1985.
Molecular cloning of tetracycline resistance genes from Streptomyces rimosus in Streptomyces griseus and characterization of the cloned genes.
J. Bacteriol.
161:1010-1016[Abstract/Free Full Text].
|
| 41.
|
Rebello, A.,
J. A. Gil,
J. A. Asturias,
P. Liras, and J. F. Martin.
1989.
Cloning and characterization of a phosphate regulated promoter involved in phosphate control of candicidin biosynthesis.
Gene
79:47-58[Medline].
|
| 42.
|
Rhodes, P. M.,
N. Winskill,
E. J. Friend, and M. Warren.
1981.
Biochemical and genetic characterisation of Streptomyces rimosus mutants impaired in oxytetracycline biosynthesis.
J. Gen. Microbiol.
124:329-338.
|
| 43.
|
Sambrook, J.,
E. F. Fritisch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 44.
|
Stock, J. B.,
A. J. Ninfa, and A. M. Stock.
1989.
Protein phosphorylation and regulation of adaptive responses in bacteria.
Microbiol. Rev.
53:450-490[Abstract/Free Full Text].
|
| 45.
|
Strohl, W. R.
1992.
Compilation and analysis of DNA sequences associated with apparent streptomycete promoters.
Nucleic Acids Res.
20:961-974[Abstract/Free Full Text].
|
| 46.
|
Stutzman-Engwall, K. J.,
S. L. Otten, and C. R. Hutchinson.
1992.
Regulation of metabolism in Streptomyces spp. and overproduction in Streptomyces peucetius.
J. Bacteriol.
174:144-154[Abstract/Free Full Text].
|
| 47.
|
Tang, L.,
A. Grimm,
Y. X. Zhang, and C. R. Hutchinson.
1996.
Purification and characterization of the DNA-binding protein Dnr1, a transcriptional factor of daunorubicin biosynthesis in Streptomyces peucetius.
Mol. Microbiol.
22:801-813[Medline].
|
| 48.
|
Thomas, R., and D. J. Williams.
1983.
Oxytetracycline biosynthesis: mode of incorporation of [1-13C] and [1,2-13C2] acetate.
J. Chem. Soc. Chem. Commun.
12:677-679.
|
| 49.
|
Wanner, B. L.,
M. R. Wilmes, and D. C. Young.
1988.
Control of bacterial alkaline phosphatase synthesis and variation in an Escherichia coli K-12 phoR mutant by adenyl cyclase, the cyclic AMP receptor protein, and the phoM operon.
J. Bacteriol.
170:1092-1102[Abstract/Free Full Text].
|
| 50.
|
Wanner, B. L., and M. R. Wilmes-Riesenberg.
1992.
Involvement of phosphotransacetylase, acetate kinase, and acetyl phosphate synthesis in the control of the phosphate regulon in Escherichia coli.
J. Bacteriol.
174:2124-2130[Abstract/Free Full Text].
|
| 51.
|
Wanner, B. L.
1996.
Phosphorus assimilation and control of the phosphate regulon, p. 1357-1381.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, W. S. Reznikoff, M. Riley, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
|
| 52.
|
Westpheling, J. E.,
M. Raines, and R. Losick.
1985.
RNA polymerase heterogeneity in Streptomyces coelicolor.
Nature
313:22-27[Medline].
|
| 53.
|
Wietzorrek, A., and M. J. Bibb.
1997.
A novel family of proteins that regulates antibiotic production in Streptomyces appears to contain an OmpR-like DNA-binding fold.
Mol. Microbiol.
25:1181-1184[Medline].
|
| 54.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[Medline].
|
| 55.
|
Zhang, J. Y., and A. L. Demain.
1991.
Regulation of ACV synthetase in penicillin-producing and cephalosporin-producing microorganisms.
Biotechnol. Adv.
9:623-641.
[Medline] |
Journal of Bacteriology, May 1999, p. 3025-3032, Vol. 181, No. 10
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Alduina, R., Piccolo, L. L., D'Alia, D., Ferraro, C., Gunnarsson, N., Donadio, S., Puglia, A. M.
(2007). Phosphate-Controlled Regulator for the Biosynthesis of the Dalbavancin Precursor A40926. J. Bacteriol.
189: 8120-8129
[Abstract]
[Full Text]
-
Higashi, T., Iwasaki, Y., Ohnishi, Y., Horinouchi, S.
(2007). A-Factor and Phosphate Depletion Signals Are Transmitted to the Grixazone Biosynthesis Genes via the Pathway-Specific Transcriptional Activator GriR. J. Bacteriol.
189: 3515-3524
[Abstract]
[Full Text]
-
Petkovic, H., Cullum, J., Hranueli, D., Hunter, I. S., Peric-Concha, N., Pigac, J., Thamchaipenet, A., Vujaklija, D., Long, P. F.
(2006). Genetics of Streptomyces rimosus, the Oxytetracycline Producer. Microbiol. Mol. Biol. Rev.
70: 704-728
[Abstract]
[Full Text]
-
Ghorbel, S., Smirnov, A., Chouayekh, H., Sperandio, B., Esnault, C., Kormanec, J., Virolle, M.-J.
(2006). Regulation of ppk Expression and In Vivo Function of Ppk in Streptomyces lividans TK24.. J. Bacteriol.
188: 6269-6276
[Abstract]
[Full Text]
-
Peric-Concha, N., Borovicka, B., Long, P. F., Hranueli, D., Waterman, P. G., Hunter, I. S.
(2005). Ablation of the otcC Gene Encoding a Post-polyketide Hydroxylase from the Oxytetracyline Biosynthetic Pathway in Streptomyces rimosus Results in Novel Polyketides with Altered Chain Length. J. Biol. Chem.
280: 37455-37460
[Abstract]
[Full Text]
-
Anukool, U., Gaze, W. H., Wellington, E. M. H.
(2004). In Situ Monitoring of Streptothricin Production by Streptomyces rochei F20 in Soil and Rhizosphere. Appl. Environ. Microbiol.
70: 5222-5228
[Abstract]
[Full Text]
-
Martin, J. F.
(2004). Phosphate Control of the Biosynthesis of Antibiotics and Other Secondary Metabolites Is Mediated by the PhoR-PhoP System: an Unfinished Story. J. Bacteriol.
186: 5197-5201
[Full Text]
-
Sola-Landa, A., Moura, R. S., Martin, J. F.
(2003). The two-component PhoR-PhoP system controls both primary metabolism and secondary metabolite biosynthesis in Streptomyces lividans. Proc. Natl. Acad. Sci. USA
100: 6133-6138
[Abstract]
[Full Text]